Order Article Reprints

Lin H-Y, Yu C-C, Chi C-L, Wei C-K, Yin W-Y, Tseng C-E, Li S-C. Peptidylarginine Deiminase Type 2 Predicts Tumor Progression and Poor Prognosis in Patients with Curatively Resected Biliary Tract Cancer. Cancers. 2023; 15(16):4131. https://doi.org/10.3390/cancers15164131

Lin, Hon-Yi, Chih-Chia Yu, Chen-Lin Chi, Chang-Kuo Wei, Wen-Yao Yin, Chih-En Tseng, and Szu-Chin Li. 2023. "Peptidylarginine Deiminase Type 2 Predicts Tumor Progression and Poor Prognosis in Patients with Curatively Resected Biliary Tract Cancer" Cancers 15, no. 16: 4131. https://doi.org/10.3390/cancers15164131

Lin, H. -Y., Yu, C. -C., Chi, C. -L., Wei, C. -K., Yin, W. -Y., Tseng, C. -E., & Li, S. -C. (2023). Peptidylarginine Deiminase Type 2 Predicts Tumor Progression and Poor Prognosis in Patients with Curatively Resected Biliary Tract Cancer. Cancers, 15(16), 4131. https://doi.org/10.3390/cancers15164131